Funds · 13F filer · Luxembourg, N4

Artal Group S.A.

$931.1M in 2 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return+16.8%S&P 500 +20.9%
3y return+45.8%S&P 500 +68.5%
5y return−35.0%S&P 500 +74.5%
10y return+8.1%S&P 500 +256.5%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since June 30, 2016: $108 against $357 in the S&P 500.2

Artal Group S.A.S&P 500 (SPY)
$55$100$35720162026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
CAVACava Group Inc$510.7M54.9%−31.6%
LXRXLexicon Pharmaceuticals Inc$420.4M45.1%+13.2%

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
CAVACava Group IncJune 30, 2023+91.6%$510.7M
LXRXLexicon Pharmaceuticals IncJune 30, 2020+20.3%$420.4M

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026+10.6%+14.8%
March 31, 2026+37.4%−4.6%
December 31, 2025−5.7%+2.4%
September 30, 2025−18.4%+7.8%
June 30, 2025+5.1%+10.5%
March 31, 2025−24.6%−4.6%
December 31, 2024−12.9%+2.1%
September 30, 2024+20.7%+5.4%
June 30, 2024+5.0%+4.0%
March 31, 2024+37.8%+10.0%
December 31, 2023+39.5%+11.2%
September 30, 2023−25.7%−3.6%
June 30, 2023+7.4%+8.3%
March 31, 2023−2.0%+7.0%
December 31, 2022−8.7%+7.1%
September 30, 2022+2.2%−5.3%
June 30, 2022−17.6%−16.5%
March 31, 2022−29.4%−4.9%
December 31, 2021−15.0%+10.7%
September 30, 2021−8.3%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1053906
  2. 2
    Filed August 13, 2026 · accession 0001053906-26-000008